 |
Santhera Pharmaceuticals Holding AG (VTX:SANN) Santhera Presents Preclinical Data On Oral MC4 Receptor Antagonists for Treatment Of Cancer Cachexia At AICR Research Conference
NOV 7, 2008 16:03 - Article Views: 806
Santhera Pharmaceuticals Holding AG (VTX:SANN) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------
|
 |
|
Santhera Pharmaceuticals Holding AG (VTX:SANN) Santhera Raises CHF 15.9 Million In Private Placement With Strategic Investor Ares Life Sciences
NOV 6, 2008 16:03 - Article Views: 609
Santhera Pharmaceuticals Holding AG (VTX:SANN) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------
|
|
|
Santhera Pharmaceuticals Holding AG (SWF:SANN) Santhera Enrolls Last Patient In Pivotal US Phase III With Snt-mc17/idebenone In Friedreich's Ataxia
OCT 31, 2008 17:17 - Article Views: 473
Santhera Pharmaceuticals Holding AG (SWF:SANN) Corporate news announcement processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------
|
|
|
Santhera Pharmaceuticals Holding AG (SWF:SANN) Santhera Launches CATENA® In Canada
OCT 10, 2008 15:29 - Article Views: 922
Santhera Pharmaceuticals Holding AG (SWF:SANN) Corporate news announcement processed and transmitted by Hugin ASA. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------
|
|
|
Santhera Pharmaceuticals Holding AG (SWF:SANN) Publication In European Heart Journal Highlights Potential Of
Santhera's SNT-MC17/idebenone In Duchenne Muscular Dystrophy
SEP 25, 2008 15:27 - Article Views: 932
Santhera Pharmaceuticals Holding AG (SWF:SANN) Corporate news announcement processed and transmitted by Hugin ASA. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------
|
|
|
Santhera Pharmaceuticals Holding AG (SWF:SANN) Santhera's 2008 Interim Results Reflect Advances In Clinical
Development And Preparation For First Product Launch
AUG 22, 2008 15:03 - Article Views: 671
Santhera Pharmaceuticals Holding AG (SWF:SANN) Corporate news announcement processed and transmitted by Hugin ASA. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------
|
|
|
Santhera Pharmaceuticals Holding AG (SWF:SANN) Santhera's Omigapil Receives Orphan Drug Designation From FDA And
Emea
AUG 15, 2008 15:19 - Article Views: 1,050
Santhera Pharmaceuticals Holding AG (SWF:SANN) Corporate news announcement processed and transmitted by Hugin ASA. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------
|
|
|
Santhera Provides Update On Clinical/Regulatory Processes With
Snt-mc17/idebenone For The Treatment Of Friedreich's Ataxia
AUG 10, 2008 18:41 - Article Views: 448
Santhera Pharmaceuticals Holding AG (SWF:SANN) Corporate news announcement processed and transmitted by Hugin ASA. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------
|
|
|
Santhera's Ongoing Studies Prevent CHMP Review Under Small Patient
Populations Guideline - Company Expects Negative CHMP Opinion On MAA
for SNT-MC17/Idebenone In Friedreich's Ataxia
JULY 25, 2008 03:01 - Article Views: 550
Santhera Pharmaceuticals Holding AG Corporate news announcement processed and transmitted by Hugin ASA. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- --------------
|
|
